SCI Abstract

search
Treatment and prognostic implications of strong PD-L1 expression in primary hepatic sarcomatoid carcinoma
Treatment and prognostic implications of strong PD-L1 expression in primary hepatic sarcomatoid carcinoma
Primary hepatic sarcomatoid carcinoma (HSC) is an extremely rare and aggressive subtype of primary liver cancer. HSC has u...
Facilitated subcutaneous immunoglobulin treatment patterns in pediatric patients with primary immunodeficiency diseases
Facilitated subcutaneous immunoglobulin treatment patterns in pediatric patients with primary immunodeficiency diseases
Aim: This retrospective study investigated real-world hyaluronidase-facilitated subcutaneous immunoglobulin (fSCIG) treatm...
Association between sex and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis
Association between sex and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis
Aim: To explore the association between sex and immune checkpoint inhibitors (ICIs). Materials & methods: We assessed ...
A rare case of daratumumab-associated encephalopathy in multiple myeloma
A rare case of daratumumab-associated encephalopathy in multiple myeloma
Aim: Daratumumab, a CD38 monoclonal antibody, has been widely used in patients with multiple myeloma. Although a variety o...
Metastatic gastric cancer: synergizing and sequencing targeted therapy with first-line immunotherapy
Metastatic gastric cancer: synergizing and sequencing targeted therapy with first-line immunotherapy
The authors have no financial involvement with any organization or entity with a financial interest in or financial confli...
Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-158
Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-158
Aim: To evaluate pembrolizumab in patients of Chinese descent with microsatellite instability-high (MSI-H)/deficient misma...
The role of ixekizumab in the treatment of nonradiographic axial spondyloarthritis
The role of ixekizumab in the treatment of nonradiographic axial spondyloarthritis
Nonradiographic axial spondyloarthritis (nr-axSpA) is a subtype of SpA with undeveloped definite radiographic sacroiliitis...
Are immune checkpoint inhibitors safe and effective in lung cancer patients with pre-existing interstitial lung disease?
Are immune checkpoint inhibitors safe and effective in lung cancer patients with pre-existing interstitial lung disease?
Aim: This study aims to clarify the efficacy and adverse effects of immune checkpoint inhibitors (ICIs) in the lung cancer...
Certolizumab pegol in the treatment of axial spondyloarthritis
Certolizumab pegol in the treatment of axial spondyloarthritis
Axial spondyloarthritis is a chronic, immune-mediated systemic inflammatory disease encompassing ankylosing spondylitis an...
Sintilimab-induced severe erosive hemorrhagic gastritis and pyloric obstruction: a case report and literature review
Sintilimab-induced severe erosive hemorrhagic gastritis and pyloric obstruction: a case report and literature review
Immune checkpoint inhibitors could restore immune surveillance to attack tumor through targeting CTLA-4, PD-1 or PD-L1, an...
Effectiveness of allergen immunotherapy with house dust mite extract for pediatric bronchial asthma
Effectiveness of allergen immunotherapy with house dust mite extract for pediatric bronchial asthma
Aim: We compared the effectiveness of rush subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) using sta...
Serplulimab monotherapy in extensive-stage small-cell lung cancer with brain metastasis: a case report
Serplulimab monotherapy in extensive-stage small-cell lung cancer with brain metastasis: a case report
Small-cell lung cancer (SCLC) is an aggressive form of lung cancer with limited treatment options, especially for extensiv...
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease
Risankizumab is a humanized monoclonal antibody that inhibits the p19 subunit of IL-23 cytokine. Recently it has been appr...
Adherence, persistence and treatment switching in psoriasis
Adherence, persistence and treatment switching in psoriasis
Aim: This study aims to investigate drug utilization patterns in the treatment of psoriasis (PsO) from 1 to 5 years in a r...
What is the future of immune checkpoints inhibitors for metastatic triple negative breast cancers?
What is the future of immune checkpoints inhibitors for metastatic triple negative breast cancers?
*CONTACT: E-mail Address: ramondemello@gmail.comhttps://orcid.org/0000-0002-9640-4573Department of Oncology, Oxford Cancer...